United Kingdom · Question · Written question
UIN 192548
Gene Therapies
Original
Introduced
5 July 2023
Last action
11 July 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
11 July 2023
Summary
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence’s Single Technology Appraisal pathway is compatible with emerging innovations including gene therapies.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 July 2023
Written question
To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence’s Single Technology Appraisal pathway is compatible with emerging innovations including gene therapies.
Source: Commons
11 July 2023
Answer
The National Institute for Health and Care Excellence (NICE) evaluates gene therapies through both its technology appraisal programme and its highly specialised technologies programmes as appropriate. NICE’s processes have been proven to be suitable for t...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-07-05/192548
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1650376
- uk · wq-1650376 · source updated 11 July 2023